Published in Antimicrob Agents Chemother on March 01, 2000
Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother (2000) 1.79
Intrinsic and acquired resistance mechanisms in enterococcus. Virulence (2012) 1.59
Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice. Antimicrob Agents Chemother (2006) 1.43
Comparative analysis of sequences flanking tet(W) resistance genes in multiple species of gut bacteria. Antimicrob Agents Chemother (2006) 1.42
Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering. Antimicrob Agents Chemother (2001) 1.26
vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother (2010) 1.25
Members of the genera Paenibacillus and Rhodococcus harbor genes homologous to enterococcal glycopeptide resistance genes vanA and vanB. Antimicrob Agents Chemother (2004) 0.98
Vancomycin resistant enterococci in farm animals - occurrence and importance. Infect Ecol Epidemiol (2012) 0.92
Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil. Antimicrob Agents Chemother (2005) 0.89
Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van gene homologue expression directing the synthesis of a modified cell wall peptidoglycan. Antimicrob Agents Chemother (2007) 0.86
Putative VanRS-like two-component regulatory system associated with the inducible glycopeptide resistance cluster of Paenibacillus popilliae. Antimicrob Agents Chemother (2005) 0.80
First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia. Emerg Infect Dis (2002) 0.77
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med (1999) 10.21
Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive cocci. Cell (1991) 7.17
Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol (1993) 6.96
Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett (1992) 6.12
Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev Vet Med (1997) 2.94
Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583. J Bacteriol (1996) 2.87
Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother (1995) 2.11
The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene (1995) 2.09
Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother (1997) 2.03
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother (1999) 1.95
Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob Agents Chemother (1998) 1.80
DNA sequence variation within vanA, vanB, vanC-1, and vanC-2/3 genes of clinical Enterococcus isolates. Antimicrob Agents Chemother (1998) 1.79
Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339. J Bacteriol (1999) 1.67
vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother (1995) 1.28
A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. J Infect Dis (1999) 1.13
Vancomycin-resistant Bacillus circulans carrying the vanA gene responsible for vancomycin resistance in enterococci. Eur J Clin Microbiol Infect Dis (1997) 1.08
Rapid acquisition of unknown DNA sequence adjacent to a known segment by multiplex restriction site PCR. Biotechniques (1998) 1.04
In vitro conjugative transfer of VanA vancomycin resistance between Enterococci and Listeriae of different species. Eur J Clin Microbiol Infect Dis (1996) 1.01
Isolation of glycopeptide-resistant enterococci from chicken in Japan. Antimicrob Agents Chemother (1998) 0.95
DNA sequence resembling vanA and vanB in the vancomycin-resistant biopesticide Bacillus popilliae. J Infect Dis (1998) 0.84
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis (1998) 3.96
Unique biochemical events in bacterial sporulation. Annu Rev Microbiol (1970) 3.11
Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc (1997) 2.62
Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. J Clin Microbiol (1997) 2.61
Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs. J Clin Microbiol (2003) 2.57
Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis (2006) 2.53
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin Microbiol Rev (1988) 2.48
Leclercia adecarboxylata infections: case report and review. Clin Infect Dis (1997) 2.46
Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J Infect Dis (1995) 2.37
Comparative studies of the mosquito-larval toxin of Bacillus sphaericus SSII-1 and 1593. Can J Microbiol (1979) 2.36
Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc (1995) 2.17
Staphylococcus lugdunensis endocarditis: a complication of vasectomy? Mayo Clin Proc (1999) 2.17
Detection of herpes simplex virus DNA in genital and dermal specimens by LightCycler PCR after extraction using the IsoQuick, MagNA Pure, and BioRobot 9604 methods. J Clin Microbiol (2001) 2.16
Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis (1997) 2.04
Infective endocarditis caused by HACEK microorganisms. Annu Rev Med (1997) 2.03
Comparison of protein A gene sequencing with pulsed-field gel electrophoresis and epidemiologic data for molecular typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2000) 2.03
Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates. J Clin Microbiol (1998) 2.02
Sporulation of tricarboxylic acid cycle mutants of Bacillus subtilis. J Bacteriol (1972) 1.87
Bacillus sphaericus: microbiological factors related to its potential as a mosquito larvicide. Adv Biotechnol Processes (1984) 1.81
DNA sequence variation within vanA, vanB, vanC-1, and vanC-2/3 genes of clinical Enterococcus isolates. Antimicrob Agents Chemother (1998) 1.79
Bacillus thuringiensis: microbiological considerations. Annu Rev Microbiol (1969) 1.74
Direct detection of Legionella species from bronchoalveolar lavage and open lung biopsy specimens: comparison of LightCycler PCR, in situ hybridization, direct fluorescence antigen detection, and culture. J Clin Microbiol (2001) 1.69
Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. J Clin Microbiol (2001) 1.68
Clinical comparison of the isolator and BacT/Alert aerobic blood culture systems. J Clin Microbiol (1995) 1.67
Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience. J Clin Microbiol (2000) 1.65
Localization of a mosquito-larval toxin of Bacillus sphaericus 1593. Appl Environ Microbiol (1980) 1.64
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis (1996) 1.63
Traveling toothpicks. Mayo Clin Proc (1983) 1.61
Metabolism of Bacillus thuringiensis in relation to spore and crystal formation. J Bacteriol (1969) 1.60
Comparison of Gen-Probe Group A streptococcus Direct Test with culture for diagnosing streptococcal pharyngitis. J Clin Microbiol (1994) 1.59
Bacteremia due to Enterococcus avium. Clin Infect Dis (1993) 1.57
Cloning and sequencing of the gene encoding a 125-kilodalton surface-layer protein from Bacillus sphaericus 2362 and of a related cryptic gene. J Bacteriol (1989) 1.56
Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex. J Clin Microbiol (1997) 1.52
Cosegregation of a novel Bartonella species with Borrelia burgdorferi and Babesia microti in Peromyscus leucopus. J Infect Dis (1998) 1.52
Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc (1989) 1.51
Toxic activity of Bacillus sphaericus SSII-1 for mosquito larvae. Infect Immun (1978) 1.47
Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis (1996) 1.46
Direct identification of bacteria from positive blood cultures by amplification and sequencing of the 16S rRNA gene: evaluation of BACTEC 9240 instrument true-positive and false-positive results. J Clin Microbiol (2001) 1.44
Artificial Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial. J Heart Valve Dis (1999) 1.42
Follow-up MR imaging in patients with pyogenic spine infections: lack of correlation with clinical features. AJNR Am J Neuroradiol (2007) 1.42
Outpatient costing and classification: are we any closer toa national standard for ambulatory classification systems? Med J Aust (1998) 1.40
Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs. J Clin Microbiol (2004) 1.38
Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J Infect Dis (1997) 1.37
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis (1999) 1.36
Prosthetic joint infection due to Staphylococcus lugdunensis. Mayo Clin Proc (2000) 1.35
Urinary tract infection caused by nontyphoidal Salmonella: report of 30 cases. Urol Int (1992) 1.33
Linezolid therapy of Staphylococcus aureus experimental osteomyelitis. Antimicrob Agents Chemother (2000) 1.30
Evaluation of two rapid antigen assays, BioStar Strep A OIA and Pacific Biotech CARDS O.S., and culture for detection of group A streptococci in throat swabs. J Clin Microbiol (1994) 1.28
Metalloprotease from Bacillus thuringiensis. Appl Microbiol (1975) 1.28
Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. Clin Infect Dis (1998) 1.24
Pulmonary disease in the immunocompromised host (2). Mayo Clin Proc (1985) 1.21
Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am (2000) 1.21
In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis (2000) 1.19
Comparison of Du Pont Isolator and Roche Septi-Chek for detection of fungemia. J Clin Microbiol (1987) 1.19
A comparison of 16S ribosomal DNA sequences from five isolates of Helicobacter pylori. Int J Syst Bacteriol (1994) 1.17
Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin. J Clin Microbiol (1997) 1.17
The dnaB-pheA (256 degrees-240 degrees) region of the Bacillus subtilis chromosome containing genes responsible for stress responses, the utilization of plant cell walls and primary metabolism. Microbiology (1996) 1.13
Epidemic of pulmonary blastomycosis (Namekagon fever) in Wisconsin canoeists. Chest (1984) 1.12
Evaluation of an immunoassay for direct detection of Escherichia coli O157 in stool specimens. J Clin Microbiol (1995) 1.11
The initial outpatient-physician encounter in group A streptococcal necrotizing fasciitis. Clin Infect Dis (2000) 1.10
Pulmonary disease in the immunocompromised host. 1. Mayo Clin Proc (1985) 1.09
Clinical evaluation of the Gen-Probe Amplified Direct Test for detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid. J Clin Microbiol (1998) 1.08
Quantitative blood cultures in candidemia. Mayo Clin Proc (1991) 1.07
Evaluation of the Alexon-trend ProSpecT Campylobacter microplate assay. J Clin Microbiol (2000) 1.07
Assessment of invasion frequencies of cultured HEp-2 cells by clinical isolates of Helicobacter pylori using an acridine orange assay. J Clin Pathol (1998) 1.06
Ketolide treatment of Haemophilus influenzae experimental pneumonia. Antimicrob Agents Chemother (1999) 1.06
Clinical comparison of the Treponema pallidum CAPTIA syphilis-G enzyme immunoassay with the fluorescent treponemal antibody absorption immunoglobulin G assay for syphilis testing. J Clin Microbiol (1999) 1.04
Prosthetic joint infection diagnosed postoperatively by intraoperative culture. Clin Orthop Relat Res (2005) 1.04
Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits. Antimicrob Agents Chemother (1992) 1.04
Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis (2010) 1.04
Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. J Med Genet (2003) 1.03
Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc (1999) 1.03
In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis (1998) 1.03
Laboratory methods for the diagnosis of disseminated histoplasmosis: clinical importance of the lysis-centrifugation blood culture technique. Mayo Clin Proc (1987) 1.02
Insecticidal activity of Bacillus laterosporus. J Invertebr Pathol (1985) 1.02
Subarachnoid haemorrhage associated with infectious endocarditis: case report and literature review. Eur J Neurol (2002) 1.01
Empiric therapy with moxalactam alone in patients with bacteremia. Mayo Clin Proc (1984) 1.00
Lactobacillemia in liver transplant patients. Clin Infect Dis (1994) 1.00
Oxygen metabolism of catalase-negative and catalase-positive strains of Lactobacillus plantarum. J Bacteriol (1975) 0.99
Prosthetic joint infection due to Mycobacterium tuberculosis: a case series and review of the literature. Am J Orthop (Belle Mead NJ) (1998) 0.98
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis (1998) 0.98
Frequency of isolation of Staphylococcus lugdunensis in consecutive urine cultures and relationship to urinary tract infection. J Clin Microbiol (2002) 0.97
Comparison between bacteriophage typing and serotyping for the differentiation of Bacillus sphaericus strains. Ann Microbiol (Paris) (1981) 0.97
Carbohydrate metabolism in the mosquito pathogen Bacillus sphaericus 2362. Appl Environ Microbiol (1989) 0.96
A method for the isolation of asporogenic mutants of Bacillus thuringiensis. Can J Microbiol (1978) 0.96
Performance of five agar media for recovery of fungi from isolator blood cultures. J Clin Microbiol (2000) 0.96
Use of polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis to detect a point mutation in the catalase-peroxidase gene (katG) of Mycobacterium tuberculosis. Mol Cell Probes (1997) 0.96
Transfer of Bacillus lentimorbus and Bacillus popilliae to the genus Paenibacillus with emended descriptions of Paenibacillus lentimorbus comb. nov. and Paenibacillus popilliae comb. nov. Int J Syst Bacteriol (1999) 0.95
Mitral stenosis associated with valvular tophi. Mayo Clin Proc (1984) 0.95
Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc (2000) 0.93